Abstract:Abstract Background: Plasmodium vivax remains the predominant species at the China–Myanmar border, imposing a major challenge to the recent gains in regional malaria elimination. To closely supervise the emerging of drug resistance in this area, we surveyed the variations in genes potentially correlated with drug resistance in P. vivax parasite and the possible drug selection with time. Methods: A total of 235 P. vivax samples were collected from patients suffering uncomplicated malaria at Yingjiang, Tengchong, and Longling counties, and Nabang port in China, Yunnan province, and Laiza township in Myanmar, during 2008 to 2017. Five potential drug resistance genes were amplified utilizing nested-PCR and analyzed, including pvdhfr, pvdhps, pvmdr1, pvcrt-o , and pvk12 . Results: The pvdhfr F57I/L, S58R, T61M and S117T/N presented in 40.64%, 56.68%, 40.11%, and 56.04% of the sequenced P. vivax isolates, and these mutations significantly decreased with years. The haplotype formed by these quadruple mutations predominated at Yingjiang, Tengchong, Longling and Nabang. While a mutation H99S/R (56.59%) dominated at Laiza and increased with time. In pvdhps , the A383G prevailed in 69.16% of the samples, which remained the most prevalent haplotype. However, a significant decrease of its occurrence was also noticed over the time. The S382A/C and A553G existed in 8.37% and 30.84% of the isolates, respectively. In pvmdr1 , the mutation Y976F occurred at a low frequency in 5/232 (2.16%), while T958M was fixed and F1076L was approaching fixed (72.41%). The K10 insertion was detected at an occurrence of 33.17% in pvcrt-o , whereas there was no significant difference among the sites or over the time. No mutation was identified in pvk12 . Conclusions: Mutations related with resistance to antifolate drugs are prevalent in this area as expected, while their frequencies decrease significantly with time, suggestive of increased susceptibility of P. vivax parasite to antifolate drugs. Resistance to CQ is possibly emerging. However, since the molecular mechanisms underneath CQ resistance is yet to be better understood, close supervision of clinical drug efficiency and continuous function investigation is urgently needed to alarm drug resistance.

Association study of Plasmodium falciparum Acetyl-CoA Synthetase Mutations S868G and V949I with antimalarial drugs

Lack of Association of the S769N Mutation in Plasmodium Falciparum SERCA (pfatp6) with Resistance to Artemisinins

Plasmodium falciparum multidrug resistance 1 gene polymorphisms associated with outcomes after antimalarial treatment

First Detection in West Africa of a Mutation That May Contribute to Artemisinin Resistance <i>Plasmodium falciparum</i>

Genome-wide Association Analysis Identifies Genetic Loci Associated with Resistance to Multiple Antimalarials in Plasmodium Falciparum from China-Myanmar Border

Mutation in the 26S proteasome regulatory subunit rpn2 gene in Plasmodium falciparum confers resistance to artemisinin

First Detection in West Africa of a Mutation That May Contribute to Artemisinin Resistance Plasmodium falciparum

Evaluation of the Effect of Gene Duplication by Genome Editing on Drug Resistance in Plasmodium falciparum

Anti-folate Combination Therapies and Their Effect on the Development of Drug Resistance in Plasmodium Vivax

Polymorphism of Antifolate Drug Resistance in Plasmodium vivax From Local Residents and Migrant Workers Returned From the China-Myanmar Border

Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model.

Molecular Surveillance and in Vitro Drug Sensitivity Study of Plasmodium Falciparum Isolates from the China-Myanmar Border.

Polymorphisms in Plasmodium Falciparum Adenosine Triphosphatase 6 (pfatpase6) Gene and Their Significance in Finding the Genetic Marker Forartemisinin Resistance

Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs

The potential role of CI-679 against artemisinin-resistant Plasmodium falciparum

Single-nucleotide polymorphisms of artemisinin resistance-related pfubp1 and pfap2mu genes in imported Plasmodium falciparum to Wuhan, China

High Frequency Mutations in pfdhfr and pfdhps of Plasmodium falciparum in Response to Sulfadoxine-Pyrimethamine: A Cross-Sectional Survey in Returning Chinese Migrants From Africa

Insight into molecular diagnosis for antimalarial drug resistance of Plasmodium falciparum parasites: a review

Absence of association between Pfnfs1 mutation and in vitro susceptibility to lumefantrine in Plasmodium falciparum

Genetic background and PfKelch13 affect artemisinin susceptibility of PfCoronin mutants in Plasmodium falciparum

Polymorphisms of Potential Drug Resistant Molecular Markers in Plasmodium Vivax From China–Myanmar Border During 2008 to 2017